Bio-thera Solutions

This study tests an experimental drug called BAT4406F in 192 people with two rare kidney conditions: Minimal Change Disease and Focal Segmental Glomerulosclerosis. The goal is to see if the drug can reduce protein in urine and prevent disease relapses. Participants will receive e…

This study compares a new drug called BAT3306 to the approved drug Keytruda in people with stage IB to IIIA non-small cell lung cancer whose tumors have been completely removed by surgery. The goal is to see if BAT3306 works similarly in the body as an additional treatment after …

This study is testing an experimental drug, BAT8008, in about 182 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the highest safe dose, and see how the body processes it. This is an early-phase…

This study tests a new medicine called BAT5906 against an approved drug (ranibizumab) for people with diabetic macular edema, a condition that causes vision loss. About 406 adults with type 1 or type 2 diabetes will receive injections into the eye over a year. The goal is to see …